Oncostatin M in Ulcerative Colitis Patients
NCT05974332 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 99
Last updated 2023-08-03
Summary
Ulcerative colitis (UC) is a refractory disease characterized by symptoms such as diarrhea, bloody stools, and abdominal pain with repeated relapses and remissions.
Conditions
Interventions
- DIAGNOSTIC_TEST
-
Oncostatin M
Test to diagnosis of Ulcerative colitis
Sponsors & Collaborators
-
Beni-Suef University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- SINGLE
- Model
- SINGLE_GROUP
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2023-08-01
- Primary Completion
- 2024-02-28
- Completion
- 2024-03-01
More Related Trials
-
Clinical Outcome of Treatment of Ulcerative Colitis in Adult
NCT06143163 ·Status: NOT_YET_RECRUITING
-
Fecal Transplant for Ulcerative Colitis
NCT03948919 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Symptom Improvement of Ulcerative Colitis After an Induction Dose of Ustekinumab in Japanese Clinical Practice
NCT04963725 ·Status: COMPLETED
-
Rutin Therapy Role in Reducing Ulcerative Colitis Severity
NCT07147842 ·Status: COMPLETED ·Phase: NA
-
Pentoxifylline in Patients With Ulcerative Colitis
NCT07349472 ·Status: RECRUITING ·Phase: PHASE2
-
Umbilical Cord Mesenchymal Stem Cells Infusion for Ulcerative Colitis
NCT01221428 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Phosphodiesterase Inhibitors, Pentoxifylline, as Adjunctive Therapy in Patients With Ulcerative Colitis.
NCT05575505 ·Status: RECRUITING ·Phase: PHASE2
-
Study of OSE-127 vs Placebo in Patients With Moderate to Severe Active Ulcerative Colitis
NCT04882007 ·Status: COMPLETED ·Phase: PHASE2
-
Pentoxifylline as Adjunctive Therapy in Patients With Ulcerative Colitis
NCT05558761 ·Status: COMPLETED ·Phase: PHASE2
-
Prospective Observational Study of Effectiveness and Safety of Filgotinib in Participants With Ulcerative Colitis (UC)
NCT05817942 ·Status: ACTIVE_NOT_RECRUITING
-
Relationship Between Baseline Burden of Disease and TDM in Ulcerative Colitis
NCT03808506 ·Status: WITHDRAWN
-
Combined Microbiota and Metabolic Signature in Ulcerative Colitis Predicts Anti-Inflammatory Therapy Success
NCT05702879 ·Status: RECRUITING
-
Comparison Between Bowel Ultrasound-based Treat to Target Versus Routine Treat to Target Strategies in Ulcerative Colitis
NCT05735665 ·Status: UNKNOWN ·Phase: NA
-
An Observational Study to Evaluate Effectiveness and Safety of Upadacitinib in Chinese Adult Participants With Moderate to Severely Active Ulcerative Colitis (UC)
NCT06838845 ·Status: RECRUITING
-
Composite Ratios Boost CRP's Power in Monitoring Ulcerative Colitis.
NCT07261579 ·Status: COMPLETED
-
CP101 for the Treatment of Ulcerative Colitis
NCT05852574 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Serum Lactate and Ulcerative Colitis
NCT05876494 ·Status: UNKNOWN
-
Clinical Study to Evaluate the Possible Efficacy of Nifuroxazide in Patient With Ulcerative Colitis
NCT05988528 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Budesonide Multimatrix(MMX) Versus Prednisolone in Management of Mild to Moderate Ulcerative Colitis
NCT05341401 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Endoscopic Ultrasound Determines Disease Activity in Crohn's Disease And Ulcerative Colitis
NCT03863886 ·Status: UNKNOWN ·Phase: NA
-
Efficacy of Subcutaneous Infliximab in Acute Severe Ulcerative Colitis: a Multicenter Retrospective Study
NCT06998797 ·Status: NOT_YET_RECRUITING
-
Synbiotic Treatment of Ulcerative Colitis Patients
NCT00803829 ·Status: COMPLETED ·Phase: NA
-
Fecal Microbiota Transplantation in Pediatric Ulcerative Colitis (UC)
NCT05679622 ·Status: RECRUITING ·Phase: NA
-
Faecal Microbiota Transplantation in Ulcerative Colitis
NCT01896635 ·Status: COMPLETED ·Phase: PHASE2
-
An Investigation of Oral BT051 in Subjects With Moderately to Severely Active Ulcerative Colitis (UC)
NCT05084261 ·Status: COMPLETED ·Phase: PHASE1